Q1 2020
Released Apr 2, 2020, before the open
10-Q filed May 6, 2020, 36 days after period end · 0001493152-20-007823
Q1 2020 · 10-Q
Revenue$2.53M$2.53M +43.0% vs Q1 2019−20.0% vs Q4 2019
Net Income-$1.10M-$1.10M N/M vs Q1 2019N/M vs Q4 2019
EPS Diluted-$0.13-$0.13 N/M vs Q1 2019no prior Q4 2019 on file
Gross Profit$1,491,000+49.4%
Operating Income-$1,026,000N/M
Operating Cash Flow-$1,840,000N/M
Margins · derived
Gross margin59.0%+2.5 pt vs Q1 2019
Operating margin-40.6%+33.0 pt vs Q1 2019
Net margin-43.4%+32.8 pt vs Q1 2019
What the release said
The release
Same quarter
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $2.53M | $1.77M | $985.00K | $734.00K |
| Net Income | -$1.10M | -$1.35M | -$1.43M | -$680.00K |
| EPS Diluted | -$0.13 | -$0.20 | -$0.03 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nephros Inc · CIK 1196298 · Engraved from SEC EDGAR